Educadores y educandos en ciencias de la salud y la atención de la salud

Keyphrases

1. Peruvian 100%
2. Older People 78%
3. Angiotensin-converting Enzyme 71%
4. Meta-analysis 71%
5. Peru 66%
6. SARS-CoV-2 Infection 66%
7. Lima 65%
8. COVID-19 55%
9. Unbound Bilirubin 48%
10. Genotype 47%
11. Emergency Department 40%
12. Hospitalized Patients 38%
13. Polymorphism 34%
14. Confidence Interval 33%
15. Angiotensin-converting Enzyme Polymorphisms 32%
16. Genetic Variation 28%
17. Defnition 28%
18. Newborn Infant 28%
19. Total Bilirubin 28%
20. Peer Review 28%
21. Operational Definition 28%
22. Three-dimensional Scanner 28%
23. Anthropometry 28%
24. Angiotensin Receptor Blockers 28%
25. Torso 28%
26. Metformin 28%
27. Enzyme Polymorphism 25%
28. Age Groups 24%
29. Hydroxychloroquine 23%
30. Risk Factors 20%
31. COVID-19 Pandemic 20%
32. Genotype Frequency 20%
33. Peroxidase 19%
34. No Significant Difference 19%
35. Middle-aged 19%
36. Young-old 19%
37. Old Age 19%
38. Non-steroidal Anti-inflammatory Drugs (NSAIDs) 17%
39. Acute Inflammatory 17%
40. Angiotensin-converting Enzyme Inhibitor (ACEi) 17%
41. Inflammatory Markers 17%
42. Serum 25-hydroxyvitamin D 17%
43. Bilirubin Level 17%
44. Hyperbilirubinemia 17%
45. Micromethod 17%
46. Vitamin D Status 17%
47. Convenience Sampling 16%
48. Hardy-Weinberg Equilibrium 16%
49. PubMed 16%
50. Patients with Cancer 16%
51. Palliative Care 16%
52. Google Scholar 14%
53. Drug-induced Liver Injury 14%
54. Salud 14%
55. Memory Performance 14%
56. Occupational Health 14%
57. With Memory 14%
58. Icterus 14%
59. β-agonists 14%
60. Rattus Norvegicus 14%
61. Increased Mortality 14%
62. Moringa Oleifera 14%
63. Severe Acute Respiratory Syndrome Coronavirus 2 Infection 14%
64. Moringa 14%
65. Proton Pump Inhibitors 14%
66. Preschool children 14%
67. Pyrazinamide 14%
68. Gastrointestinal Bleeding 14%
69. Arteriovenous Malformation 14%
70. Verifcation 14%
71. Physical Availability 14%
72. Geographical Accessibility 14%
73. Intervention Effectiveness 14%
74. Odds Ratio 14%
75. New Coronavirus 14%
76. Chloroquine and Hydroxychloroquine 14%
77. Old Drugs 14%
78. Methodological Challenges 14%
79. Stress Diabetes 14%
80. Auditory Brainstem Response 14%
81. Low Birth Weight 14%
82. Public Health 14%
83. Type 1 Diabetes Mellitus (T1DM) 14%
84. Cholera 14%
85. Auditory Nerve Response 14%
86. Chloroquine 14%
87. Hospital-based Study 14%
88. Peak Latency 14%
89. Jejunum 14%
90. Serum Creatinine-based Equation 14%
91. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 14%
92. Muscle Strength 14%
93. Glomerular Filtration Rate 14%
94. Systematic Comparison 14%
95. Older Individuals 14%
96. Angiotensin Convertase Enzyme 14%
97. Phototherapy 14%
98. Household Survey 14%
99. Adverse Drug Reaction 14%
100. Sulfisoxazole 14%